A study recently published in the Proceedings of the American Academy of Sciences (PNAS) will bring good news to skin cancer patients, particularly those with melanoma.
With similar immunosuppression mechanisms, US scientists have removed both the main tumor and distant metastases in the bodies of experimental mice with cancer.
The first person to test the new vaccine was revealed by Moderna Therapeutics to be a lung cancer patient. This patient had a tumor but had surgery removed.
There are many types of cancer and to find a really effective method for each patient is not simple, it takes a lot of testing.